CN109988745A - A kind of extracting method of nucleus - Google Patents
A kind of extracting method of nucleus Download PDFInfo
- Publication number
- CN109988745A CN109988745A CN201810004997.6A CN201810004997A CN109988745A CN 109988745 A CN109988745 A CN 109988745A CN 201810004997 A CN201810004997 A CN 201810004997A CN 109988745 A CN109988745 A CN 109988745A
- Authority
- CN
- China
- Prior art keywords
- nucleus
- core
- cell
- cardiac
- vitro
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N5/00—Undifferentiated human, animal or plant cells, e.g. cell lines; Tissues; Cultivation or maintenance thereof; Culture media therefor
- C12N5/06—Animal cells or tissues; Human cells or tissues
- C12N5/0602—Vertebrate cells
- C12N5/0652—Cells of skeletal and connective tissues; Mesenchyme
- C12N5/0657—Cardiomyocytes; Heart cells
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2509/00—Methods for the dissociation of cells, e.g. specific use of enzymes
- C12N2509/10—Mechanical dissociation
Landscapes
- Health & Medical Sciences (AREA)
- Engineering & Computer Science (AREA)
- Biomedical Technology (AREA)
- Life Sciences & Earth Sciences (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Wood Science & Technology (AREA)
- Biotechnology (AREA)
- Organic Chemistry (AREA)
- Chemical & Material Sciences (AREA)
- Genetics & Genomics (AREA)
- Zoology (AREA)
- Cardiology (AREA)
- Microbiology (AREA)
- Rheumatology (AREA)
- Biochemistry (AREA)
- General Engineering & Computer Science (AREA)
- General Health & Medical Sciences (AREA)
- Cell Biology (AREA)
- Micro-Organisms Or Cultivation Processes Thereof (AREA)
Abstract
The invention belongs to field of biomedicine technology, it is related to a kind of method of nucleus extraction, the method that cytosol, film and nuclear leve are divided is separated especially from vitro dog ventricular muscles and isolated dog ventricular cardiac myocytes, the method of the present invention includes steps: Step 1: in vitro dog cardiac muscle cell is obtained, Step 2: subcellular is fractionated.This method helps to get largely the people's functional cell core that can be used for basic research and clinical application;It can safely and effectively realize the screening and enrichment to specific type human cell, obtained cell is made to have better biological safety;The biological characteristics that the present invention comprehensively has detected separated nucleus are sought peace function, provide reliable data for the research and application of nucleus separation, for other novel cells nucleus extraction assess provide it is a set of can method system for reference.
Description
Technical field
The invention belongs to field of biomedicine technology, are related to the method for nucleus extraction, and in particular to a kind of from vitro reality
The method for separating and extracting nucleus is tested in animal hearts cardiac muscle and ventricular muscle cell sample.
Background technique
Prior art discloses the duplication in nuclear membrane including genome and responsible DNA and transcription and nascent RNA are mature
Molecular mechanism.Some researches show that be attributed to the fact that nuclear membrane for more and more functions, including pass through receptor and its agent, ion
Channel and ionic pump and transporter separation DNA in nuclear membrane itself.This field knows, although nucleus is in structure and function
It is critically important on energy, but due to challenge relevant to internal accessibility, complete separating nucleus is simultaneously completely pure from heart cell
Change to allow the relevant knowledge of in vitro study etc. still seldom.
Studies have shown that and most of mammalian cells are conversely, because core tuberculosis during fetal growth, cardiac muscle cell
In there are non-pathology multinucleation, core is closed in dual double-layer of lipoid, is provided and is selectively entered carefully by nuclear Pore Complex
The nucleus nuclear membrane of cytoplasm, the platform that can also provide additional endocrine signal process control gene expression dose.
Nuclear membrane itself includes outer nuclear membrane and interior nuclear membrane, is separated by the core week space of 40-50nm, core and space between cells are by nuclear pore complex
It is covered, the inner surface of interior nuclear membrane is lined with the core intermediate inheritance structural network formed by lamin, in outer nuclear membrane and periphery
Matter net is connected and contains there are many protein common with periphery endoplasmic reticulum, and in contrast, interior nuclear membrane contains special with nucleus
Many different integrated membrane protein, with chromatin have direct interaction.Nearest research experiment evidence shows to include Ah
Piece sample substance, adrenergic, Endothelin and angiotensin receptor many g protein coupled receptors be positioned at nuclear membrane and adjust
Gene expression.However, being confined to the molecular pharmacology of heart nuclear membrane receptor and physiologic function is still seldom exploited, this is very big
It is attributed to that accessibility is relevant in vivo challenges and whether survive after separating with the receptor in degree, with high purity is complete
Core is from heart cell to external research.
Status based on the prior art, present inventor is quasi- to provide a kind of method of nucleus extraction, and in particular to
A method of nucleus is separated and extracted from vitro experimental animal cardiac myocytes and ventricular muscle cell sample.
Summary of the invention
It is an object of the invention to the statuses based on the prior art, provide a kind of method of nucleus extraction, and in particular to
A method of nucleus is separated and extracted from vitro experimental animal cardiac myocytes and ventricular muscle cell sample.
The invention proposes separate from from vitro experimental animal cardiac muscular tissue and isolated adult ventricular cardiac myocytes
The technical solution of complete core, the method for the present invention is based on plasma membrane for the part permeability and difference of lutern and smudge cells
With discontinuous Sucrose density centrifugation, the method for the quick separating of the cytosols such as non-nuclear membrane and nucleus is provided.
In this method, discloses and separated carefully from vitro experimental animal dog ventricular muscles and isolated dog ventricular cardiac myocytes
The method (as shown in table 1) that cell lysis matter, film and nuclear leve are divided;Since nuclear membrane is cholesterol-free, integrality is not by Radix Astragali extract for treating
Influence, in order to separate core complete and with enzymatic activity, this method is selectively mutual with sterol using infiltration plasma membrane separation
The cardiac glycoside and cardigin of effect after permeabilization, using Dounce homogenizer, then pass through differential sucrose density gradient centrifugation
(as shown in Figure 1) discharges nucleus by machinery smashing from remaining cell body, and resulting core enriching section is suitable for having
Close functional study.
Table 1: the size and density of heart subcellular organelle
Specifically, a kind of extracting method of nucleus of the invention comprising step:
Step 1: in vitro dog cardiac muscle cell is obtained,
Step 2: subcellular is fractionated.
Include step by step in step one of the invention:
1. preparing oxygenatedchemicals buffer and in relation to instrument and device for casting;
2. conventional treatment experimental animal obtains isolated experiment animal hearts;
3. in vitro experimental animal heart perfusion perfusion and digestion, obtain cardiac muscle cell.
It is all in step two of the invention to carry out on ice or under 4 degree step by step, including step by step:
1. in vitro experimental animal cardiac muscular tissue and cardiac muscle cell's homogenization;
2. tissue and cell homogenates differential centrifugation obtain the thick core and film and cytoplasm of separation;
3. discontinuous sucrose density gradient centrifugation is centrifuged again after obtaining the thick core beds of precipitation, obtains the core of separation and show thin
Long almond-shaped or circle, and to DNA stained positive;
It is all in the step 2 to carry out on ice or under 4 degree step by step.
In the present invention, isolated core is further characterized by immunofluorescence or immunoblotting.
In the present invention, the material and instrument used includes:
When cardiac muscle cell separates:
1. all programs must use ultrapure (1 type) water;
2. at room temperature, 2mM calcium ion+Tyrode solution: 136mM NaCl, 5.4mM KCl, 1mM MgCl2·6H2O, 2mM
CaCl2, 0.33mM NaH2PO4·H2O, 5mM HEPES, 10mM glucose, pH7.4;
3. room temperature not calcium ions+Tyrode solution: 136mM NaCl, 5.4mM KCl, 1mM MgCl2·6H2O,
0.33mM NaH2PO4·H2O, 5mM HEPES, 10mM glucose, pH7.4;
4. collagenase solution: not calcium ions+Tyrode solution in 100U/mL clostridiopetidase A II type, 0.1% cow's serum
Albumin (BSA);
5. at room temperature, phosphate buffered saline (PBS) (PBS): 137mM NaCl, 2.7mM KCl, 4.2mM NaH2PO4·
H2O, 1.8mM KH2PO4, pH7.4.
For isolated film, when cytosol and nuclear fraction:
1. Solubilization buffer: 300mM sucrose, 60mM KCl, 0.15mM spermine, 0.5mM EGTA, 2mM EDTA, 1mM
Dithiothreitol (DTT) (DTT), 10mg/mL BSA, 1mM MgCl2·6H2O, 50mM HEPES, pH 7.4 (at room temperature);
2. 100 × phosphatase inhibitor cocktail: 20mM NaF, 0.2M Na3VO4, 20mM beta-glycerophosphate, 0.5mM
AEBSF, 25 μ g/mL leupeptins, 10 μ g/mL Aprotinins, 1 μ g/mL pepstatin, 1 μM of Microcystin;
3. 100 × inhibitors of phosphatases and half permeabilization mixture: 20mM NaF, 0.2M Na3VO4, 20mM β-phosphoglycerol
Salt, 0.5mM AEBSF, 25 μ g/mL leupeptins, 10 μ g/mL Aprotinins, 1 μ g/mL pepstatin, 1 micro- Microcystin, 45 μ
G/mL digitonin;
4. room temperature storage buffer: 300mM sucrose, 60mM KCl, 0.5mM EGTA, 2mM EDTA, 1mM DTT, 1mM
MgCl2·6H2O, 50mM HEPES, pH 7.4 and inhibitors of phosphatases;
5. store buffer liquid: 250mM sucrose, 25mM KCl, 5mM MgCl2·6H2O, 1mM DTT, 50mM HEPES, pH
7.4 (room temperatures) and phosphatase inhibitor cocktail;
6. low Sucrose buffer: 1.85M sucrose, 25mM KCl, 5mM MgCl2·6H2O, 1mM DTT, 50mM HEPES,
PH 7.4 and inhibitors of phosphatases;
7. high-sucrose buffer: 2.15M sucrose, 25mM KCl, 5mM MgCl2·6H2O, 1mM DTT, 50mM HEPES,
PH 7.4 and inhibitors of phosphatases.
Equipment includes: Lang Dengduofu perfusion equipment;Doubles homogenizer, close and loose pestle;Polytron PT3100 is equal
Change device, model PT-DA 3012/2 disperses aggregate;Refrigeration desk centrifuge with angle and swing bucket type rotor;
Beckman Avanti ultracentrifuge band swing-rotor;Beckman Coulter Optima MAX ultracentrifuge;Poly- third
Alkene ultracentrifugation pipe (1.5,15,50mL);Copolymerization coke or inverted light microscope;Needed for Western Blot;Other experiments
When, including nylon wire (20,60,500 μm), liquid nitrogen, ice bucket, scoop, laboratory pipettor, funnel, digital balance, culture dish,
Microscopic slide, ultrasonic sound appratus, incubator, 100%O2Deng.
The present invention provides a kind of extracting methods of nucleus, especially the dog ventricle heart from dog ventricular muscles and fresh separated
The method that cytosol, film and nuclear leve are divided is separated in myocyte, method of the invention, which helps to get, largely can be used for basis
People's functional cell core of research and clinical application;It can safely and effectively realize the screening and richness to specific type human cell
Collection, makes obtained cell have better biological safety;The present invention comprehensively has detected the biological property of separated nucleus
And function, reliable data are provided for the research and application of nucleus separation, are mentioned for the nucleus of other novel cells
Take assessment provide it is a set of can method system for reference.
Detailed description of the invention
Fig. 1: subcellular is fractionated schematic diagram.
Fig. 2: the structural characterization of isolated heart cell and nucleus, wherein
Left hand view: (DIC) microscope is compared by differential interference and observes isolated rodlike cardiac muscle cell, right side two is opened
Figure: the complete purifying cardiac cell nucleus marked with fluorescent DNA dyes DRAQ5 shown with DIC or fluorescence microscope, Shang Tubao
By the enlarged drawing of the field of white edge instruction in respective image containing the following figure.
Fig. 3: the characterization of dog cardiac cell nucleus is separated by immunocytochemical stain, wherein heart core Nkx2.5,
The antibody of GATA4, HDAC5, AT1R and AT2R are decorated, and are marked with the antibody for Lamin A/C and TO-PRO-3
Core shows interior nuclear membrane and DNA respectively.
Fig. 4: the characterization that the film from dog cardiac muscle cell, cytoplasm and nuclear leve are divided, wherein
Left figure: it uses cytoplasm marker (HSP70), plasma membrane (caveolin 3), interior nuclear membrane (lamin B and A/
C), nucleopore (nucleoporin 62), and reside in transcription factor in cardiac muscle cell western blot analysis core (GATA4,
Nkx2.5);Right figure: thin by SDS-PAGE (12 hole precast gel of 4-20% gradient, every swimming lane load 20 μ g total proteins) analysis
Karyon separates the score during (film, cytoplasm and core), and is made dirty using Coomassie brilliant blue;Wherein, T, homogenate;C, cytosol;
M, membrane fraction;N, core.
Specific embodiment
Embodiment 1
Nucleus is extracted in the steps below:
Step 1: obtain in vitro dog cardiac muscle cell, including: prepare oxygenatedchemicals buffer and in relation to instrument and
Device for casting;Conventional treatment experimental animal obtains isolated experiment animal hearts;In vitro experimental animal heart perfusion perfusion and
Digestion obtains cardiac muscle cell;
Step 2: subcellular is fractionated, and including: in vitro experimental animal cardiac muscular tissue and cardiac muscle cell homogenize;
Tissue and cell homogenates differential centrifugation obtain the thick core and film and cytoplasm of separation;Discontinuous sucrose density gradient centrifugation obtains thick
It is centrifuged again after the core beds of precipitation, obtains the core of separation and shows elongated almond-shaped or circle, and to DNA stained positive;In step 2
It is all to carry out on ice or under 4 degree step by step.
More specifically, comprising:
(1) water-bath is opened, is preheated and oxygenatedchemicals buffer (100%O2): preparing suture and surgical instrument;
(2) it rinses Perfused isolated heart method device for casting with 75% ethyl alcohol to recycle 15 minutes, then with diluted pure water
After continuous flushing, rinsed with 2mM calcium ion+Tyrode primer solution;In all programs, removes all bubbles and keep constant
Flow
Obtain experimental animal heart: morphine 2mg/kg subcutaneous injection, α-chloral 120mg/kg be intravenous, heparin 10000U and
Mechanical ventilation, anaesthetizes the mongrel dogs of any gender 20-30kg, and the experimental animal carries out test tube of hepari, energy before surgery
The clot reduced in vascular system forms and prevents from being formed thrombus, and solidifies in catheterization procedure or introduce bubble and fill prevention
The tissue that fluid injection enters obstruction downstream enters the generation of cardiac muscle uniformly digested;
Routine disinfection row cardiectomy, by the above-mentioned in vitro heart of acquisition be put into the ice-cold calcium ion of 500mL+
It is rinsed in Tyrode solution, removes the tissue of remaining fat, tracheae and connection;A part of atrium sinistrum and left ventricle is perfused;
The tissue being removed is preserved for subsequent subcellular fractionation;
The perfusion of Perfused isolated heart method is with digestion: the in vitro heart aortic sinus of acquisition is connected inserting for perfusion system
Pipe, it is fixed, with calcium ion+Tyrode infusion 15 minutes, rinse remaining blood in heart;Catheter position should be able to avoid mouth
Chamber occludes and limits irrigation flow, while keeping the constant infusion temperature of 36-38 degree;Sufficient perfusion hydraulic coupling is kept, is used in combination
Tyrode infusion without calcium ion 10 minutes, by continuous circulation solution, with 200mL collagenase solution by heart perfusion about
After sixty minutes, small pieces are obtained and knit heart tissue grinding separation cell mass, suitable clostridiopetidase A and corresponding is used in digestion process
Ground modify digestion condition such as, liquor capacity, coronary artery fusion rate, best enzyme infusion time etc., with obtain it is an appropriate number of can
Row cardiac muscle cell, static rodlike heart cell show apparent tubular cross striped under an optical microscope;When necessary, it takes
Precautionary measures (1) carefully clean Lang Dengduofu equipment and replacement Tygon pipeline;(2) storage life of inventory solutions is limited;
(3) pH value of distillation water source and oxidation buffer liquid is checked at room temperature, and uses ultrapure (1 type) water, to ensure these solution
Quality etc., prevent rodlike Ca2+Tolerance cardiac muscle cell stops vigor surprisingly and reduces or calcium contamination or endotoxin are discharged into perfusion liquid
Generation;
Cell suspending liquid is filled into 50mL pipe by 500 μM of nylon cell strainers, and is centrifuged 5 points with 500rpm
Clock slowly slows down with pellet viable cells cardiac muscle cell;Cell is resuspended in the ice-cold PBS of 15mL, 5min is centrifuged with 500rpm,
It repeats once, to remove all remaining fibroblasts;
Subcellular fractionation:
1. homogenization
Cardiac muscular tissue: dissecting left ventricular tissues from the in vitro dog heart (about 1g) obtained, thoroughly clear with ice-cold PBS
It washes, and fritter is madeAfterwards, it is transferred in the 50mL Falcon pipe containing 15mL homogenate buffer, uses
Polytron PT-3100 homogenizes tissue;The homogenizer disperses skeleton equipped with 3012/2 type of PT-DA, with maximum speed
(20000rpm) sets 20s, makes pestle to the bottom of pipe at least ten times;
Cardiac muscle cell: cleaning myocyte with ice-cold PBS after digestion, at room temperature with 500rpm centrifugation 5 minutes, and will be thin
Born of the same parents' precipitating is resuspended in 15mL homogenate buffer:
2. tissue and cell homogenates differential centrifugation:
It is being slowly stirred cell or 4 DEG C in the homogenization buffer and semi-permeable mixed liquor for being supplemented with inhibitors of phosphatases
Rotation is permeated in 45 minutes, and the isotonic buffer solution chelated mineral containing 300mM sucrose Yu EDTA and EGTA is used in the present embodiment
Ion, to prevent, organelle from being damaged and protein degradation, the homogenization buffer contain spermine to stablize chromatin;
It is transferred to Dounce homogenizer, has the homogenization buffer of inhibitors of phosphatases (without red mould with isometric supplement
Element) dilution homogenate, further destroy tissue and cell and discharge nucleus, with the detergent of permeable membrane (for example, Triton-X100,
Tween 20, deoxycholic acid, digitonin), it is complete to retain nuclear membrane while permeating heart cell plasma membrane;
With 300rpm centrifugation 3 minutes (centering rotor, refrigerate desk centrifuge) at 4 DEG C, precipitates and remove uncracked
Cell, connective tissue and biggish concentration element;It is primary by 60 μm of nylon net filter supernatants, then pass through 20 μm of nylon wires
Twice, further filtering is as needed to remove most waste material and tissue residues for filtering;Centrifuge tube is transferred to centrifugation
Guan Zhong, and by being centrifuged 2000rpm centrifuge separation in swing-rotor (Sorvall 75-006-434 rotor) with 4,000 DEG C
Thick core;Supernatant pours into clean centrifuge tube, removes any remaining substance inside pipe with dust-free paper, leaves soft particle alone
(core);Keep supernatant, the thick core for the separation that suspends again in 5mL core store buffer liquid, it is ensured that collect the entire core of bottom of the tube
Particle isolates the quality of core using microscopic evaluation;At 4 DEG C (Beckman, TLA-100.3 rotors) with 38500rpm (80000
Translate) supernatant 60 minutes of centrifugation step 7, obtain film (precipitating) and cytoplasm (supernatant);The sediment of above-mentioned steps is resuspended
In film store buffer liquid, and keep film and cytoplasm fraction (supernatant) for further analyzing;
Discontinuous sucrose density gradient centrifugation:
It is drawn in the ultra-fine pipe of the ultra-fine pipe of 30mL (25 μm of 889mm), is made by the high-sucrose buffer for preparing 10ml
Standby discontinuous saccharose gradient, high-sucrose pad is Chong Die with 10 milliliters of low Sucrose buffers, the thick core always to suspend is precipitated and is laminated
Onto discontinuous saccharose gradient, when needing, at 4 DEG C with 10000rpm (12000 translate) centrifugation initial supernatant liquid (Sorvall,
SS-34 rotor) 15 minutes, make mitochondria, lysosome, peroxisome and other Cell organelle pellets, then using continuous
Saccharose gradient such as 15-35%, separates above-mentioned organelle;Optimize saccharose gradient and centrifugal condition in the present embodiment as needed
(such as time, RCF), or, the substitutes such as Percoll, Nycodens or Metrizamide substitute sugarcane using such as Ficoll
Sugar is as the culture medium for generating density gradient;
In swing type rotating cylinder (Beckman SW 28) (Beckman SW 28), ultracentrifugation pipe and 28000rpm are centrifuged
Machine is placed 60 minutes at 4 DEG C, after the completion of centrifugation, takes pipe, and is abandoned upper containing microsomal membrane and other cytoplasmic contaminants
Clear liquid wipes the remaining clast of pipe internal surface (see note 12) with dust-free paper, is needed according to experiment in nucleus store buffer liquid
In suspend again precipitating, contain pure core, be transferred to microcentrifugal tube, and fast freezing is to carry out subsequent biochemical analysis;
Isolated core does not have pollutant, and shows elongated almond or circle, and to DNA stained positive (as shown in Figure 2),
Isolated core carries out further characterization (as shown in Figure 4) by immunofluorescence (as shown in Figure 3) or immunoblotting.
Claims (7)
1. a kind of method of nucleus extraction, which is characterized in that this method is, from vitro experimental animal cardiac myocytes and ventricle
Nucleus is separated and extracted in myocyte's sample comprising is selectively interacted using infiltration plasma membrane separation with sterol strong
Heart glycosides and cardigin after permeabilization, using Dounce homogenizer, then by differential sucrose density gradient centrifugation, pass through machinery
Smashing discharges nucleus from remaining cell body, obtains core enriching section.
2. the method for nucleus extraction according to claim 1, which is characterized in that itself comprising steps of
Step 1: in vitro dog cardiac muscle cell is obtained, Step 2: subcellular is fractionated.
3. the method for nucleus extraction as described in claim 1 or 2, which is characterized in that include substep in the step one
It is rapid:
1) prepare oxygenatedchemicals buffer and in relation to instrument and device for casting;
2) conventional treatment experimental animal obtains isolated experiment animal hearts;
3) perfusion of in vitro experimental animal heart perfusion and digestion, obtain cardiac muscle cell.
4. the method for nucleus extraction as described in claim 1 or 2, which is characterized in that include substep in the step two
It is rapid:
1) in vitro experimental animal cardiac muscular tissue and cardiac muscle cell's homogenization;
2) tissue and cell homogenates differential centrifugation obtain the thick core and film and cytoplasm of separation;
3) discontinuous sucrose density gradient centrifugation is centrifuged again after obtaining the thick core beds of precipitation, is obtained the core of separation and is shown elongated
Almond-shaped or circle, and to DNA stained positive.
5. the method for nucleus extraction as described in claim 1 or 2, which is characterized in that in the step 2 it is all step by step
Carry out on ice or under 4 degree.
6. the method for nucleus extraction as described in claim 1 or 2, which is characterized in that the separation of the method cardiac myocyte
When, all programs use ultrapure 1 type water.
7. the method for nucleus extraction as described in claim 1 or 2, which is characterized in that the core separated in the method passes through
Immunofluorescence or immunoblotting are further characterized.
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN201810004997.6A CN109988745A (en) | 2018-01-03 | 2018-01-03 | A kind of extracting method of nucleus |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN201810004997.6A CN109988745A (en) | 2018-01-03 | 2018-01-03 | A kind of extracting method of nucleus |
Publications (1)
Publication Number | Publication Date |
---|---|
CN109988745A true CN109988745A (en) | 2019-07-09 |
Family
ID=67128235
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
CN201810004997.6A Pending CN109988745A (en) | 2018-01-03 | 2018-01-03 | A kind of extracting method of nucleus |
Country Status (1)
Country | Link |
---|---|
CN (1) | CN109988745A (en) |
Cited By (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN111763765A (en) * | 2020-02-18 | 2020-10-13 | 张缨 | Novel method for preventing RNA degradation of novel coronavirus sample |
CN114277094A (en) * | 2021-12-24 | 2022-04-05 | 中国农业科学院生物技术研究所 | Lysate for extracting plant cell nucleus |
Citations (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN1498269A (en) * | 2000-12-22 | 2004-05-19 | Methods for cloning mammals using reprogrammer donor chromation or doner cells | |
CN101548005A (en) * | 2006-10-06 | 2009-09-30 | 普罗梅加公司 | Methods and kits for isolating cells |
US20100184225A1 (en) * | 2005-09-30 | 2010-07-22 | Centre National De La Recherche Scientifique | Use of a cellular extract for a mitotic remodeling of chromosomes |
-
2018
- 2018-01-03 CN CN201810004997.6A patent/CN109988745A/en active Pending
Patent Citations (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN1498269A (en) * | 2000-12-22 | 2004-05-19 | Methods for cloning mammals using reprogrammer donor chromation or doner cells | |
US20100184225A1 (en) * | 2005-09-30 | 2010-07-22 | Centre National De La Recherche Scientifique | Use of a cellular extract for a mitotic remodeling of chromosomes |
CN101548005A (en) * | 2006-10-06 | 2009-09-30 | 普罗梅加公司 | Methods and kits for isolating cells |
Non-Patent Citations (3)
Title |
---|
ARTAVAZD TADEVOSYAN等,: "Isolation and study of cardiac nuclei from canine myocardium and adult ventricular myocyte", 《METHODS MOL. BIOL.》 * |
赵元茵等: "核定位信号及其分析策略", 《中国生物化学与分子生物学报》 * |
陈础: "心肌细胞内游离钙检测方法的研究进展", 《中国病理生理杂志》 * |
Cited By (4)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN111763765A (en) * | 2020-02-18 | 2020-10-13 | 张缨 | Novel method for preventing RNA degradation of novel coronavirus sample |
CN111763765B (en) * | 2020-02-18 | 2021-06-01 | 中国人民解放军东部战区总医院秦淮医疗区 | Novel method for preventing RNA degradation of novel coronavirus sample |
CN114277094A (en) * | 2021-12-24 | 2022-04-05 | 中国农业科学院生物技术研究所 | Lysate for extracting plant cell nucleus |
CN114277094B (en) * | 2021-12-24 | 2024-02-27 | 中国农业科学院生物技术研究所 | Lysate for extracting plant cell nucleus |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
US8822202B2 (en) | Apparatus and methods for cell isolation | |
US8883499B2 (en) | Systems and methods for isolating and using clinically safe adipose derived regenerative cells | |
KR101310578B1 (en) | Methods of using adipose tissue-derived cells in the treatment of cardiovascular conditions | |
US11891627B2 (en) | Mechanical apparatus and method for isolating stromal vascular fraction | |
KR20040063167A (en) | Systems and Methods for treating Patients with Processed Lipoaspirate Cells | |
MX2014006779A (en) | Method and device for sample processing. | |
US10842820B2 (en) | Kits and methods for processing stem cells from bone marrow or umbilical cord blood | |
CN105769910B (en) | Application of human amniotic mesenchymal stem cells | |
CN110777142A (en) | Method for promoting secretion of extracellular fluid by low-intensity pulse ultrasonic stimulation | |
TW201510223A (en) | Method for separating living cell and constructing cell bank by means of tissue homogenate method | |
CN113717934A (en) | Method for extracting exosomes from umbilical cord mesenchymal stem cells | |
CN109988745A (en) | A kind of extracting method of nucleus | |
CN101693884B (en) | Method for separating and extracting stem cells from placenta, umbilical cord or adipose tissue | |
CN116904394A (en) | Preparation method and application of anti-inflammatory mesenchymal stem cell-derived exosome | |
CN104818242A (en) | Separation and preparation method of primary hepatocytes | |
TWI640625B (en) | Method for rapid mincing of adipose tissues to isolate alive cells in vitro | |
CN117431214A (en) | Method for culturing frozen tumor tissue-derived organoids | |
JP2007282552A (en) | Method for cell separation and system for cell separation | |
CN113604419B (en) | Method for extracting mouse primary liver cumic cells | |
AU680828B2 (en) | Islets of Langerhan's in pure form | |
EP2032690A2 (en) | Method for the in vitro preparation of living cells and/or cell accumulations from tissue | |
CN110592005A (en) | Method for separating mesenchymal stem cells | |
EP1295936A1 (en) | Method of preparing heart muscle cells and method of searching for remedy for heart diseases | |
Ateş et al. | A modified method for isolation of rat hepatocyte: saving time increases viability | |
RU2447419C2 (en) | METHOD FOR in vitro RECOVERY OF EXPERIMENTAL TUBERCULOUS GRANULOMA IN CULTURES |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
PB01 | Publication | ||
PB01 | Publication | ||
SE01 | Entry into force of request for substantive examination | ||
SE01 | Entry into force of request for substantive examination | ||
WD01 | Invention patent application deemed withdrawn after publication |
Application publication date: 20190709 |
|
WD01 | Invention patent application deemed withdrawn after publication |